| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.09 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.09 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.077 | 0.09 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |